Q-Line Biotech (NSE:QLINE) EV-to-FCF: (As of Jun. 29, 2026)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Q-Line Biotech's Enterprise Value is ₹15,174 Mil. Q-Line Biotech does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025. Therefore, GuruFocus does not calculate Q-Line Biotech's EV-to-FCF at this moment.

The historical rank and industry rank for Q-Line Biotech's EV-to-FCF or its related term are showing as below:

NSE:QLINE' s EV-to-FCF Range Over the Past 10 Years
Min: -26.35   Med: -23.51   Max: -22.1
Current: -26.35

During the past 3 years, the highest EV-to-FCF of Q-Line Biotech was -22.10. The lowest was -26.35. And the median was -23.51.

NSE:QLINE's EV-to-FCF is ranked worse than
100% of 418 companies
in the Medical Devices & Instruments industry
Industry Median: 22.765 vs NSE:QLINE: -26.35

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-06-29), Q-Line Biotech's stock price is ₹546.50. Q-Line Biotech does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025. Therefore, GuruFocus does not calculate Q-Line Biotech's PE Ratio (TTM) at this moment.

Q-Line Biotech  (NSE:QLINE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Q-Line Biotech's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=546.50/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Q-Line Biotech EV-to-FCF Related Terms

Q-Line Biotech EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech EV-to-FCF Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
EV-to-FCF
0.00 0.00 0.00

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
EV-to-FCF 0.00 0.00 0.00

NSE:QLINE vs ABT, SYK, MDT: EV-to-FCF Comparison

For the Medical Devices subindustry, Q-Line Biotech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q-Line Biotech EV-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Q-Line Biotech's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Q-Line Biotech's EV-to-FCF falls into.


NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech EV-to-FCF Calculation

Q-Line Biotech's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=15173.742/
=

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price